Adolescent Tdap Vaccine Use Among Primary Care Physicians

Journal of Adolescent Health

Volumn 44, Issue 4, 2009, Pages 387-393

  Dempsey, Amanda F ^a   Cowan, Anne E ^a   Broder, Karen R ^b   Kretsinger, Katrina ^b   Stokley, Shannon ^b   Clark, Sarah J ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Adolescent; Pertussis; Physician attitudes; Tdap; Vaccine

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; DIPHTHERIA TETANUS TOXOID; MENINGOCOCCUS VACCINE;

ADULT; ARTICLE; BIVARIATE ANALYSIS; CLINICAL PRACTICE; CORRELATION ANALYSIS; DRUG STORAGE; DRUG UTILIZATION; FEMALE; GENERAL PRACTITIONER; HEALTH SURVEY; HUMAN; JUVENILE; MALE; MULTIVARIATE ANALYSIS; NORMAL HUMAN; PEDIATRICIAN; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; PRIORITY JOURNAL; SELF REPORT; VACCINATION;

ADOLESCENT; ADULT; ATTITUDE OF HEALTH PERSONNEL; CHILD; DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES; FEMALE; HEALTH CARE SURVEYS; HUMANS; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIANS, FAMILY; UNITED STATES; YOUNG ADULT;

EID: 62549154502     PISSN: 1054139X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jadohealth.2008.08.019     Document Type: Article

References (22)

1. Hitchcock W.P. Rationale for use of Tdap booster vaccines for adolescent immunization: Overview of efficacy, safety, and clinical use. Clin Pediatr 45 (2006) 785-794
2. McNabb S.J., Jajosky R.A., Hall-Baker P.A., et al. Summary of notifiable diseases-United States. Morbid Mortal Wkly Rep 2007 54 (2005) 1-92
3. Broder K.R., Cortese M.M., Iskander J.K., et al. Preventing tetanus, diphtheria, and pertussis among adolescents: Use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 55 RR-3 (2006) 1-34
4. Food and Drug Administration. Product approval information-licensing action, package insert: Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed ADACEL™. sanofi pasteur. Rockville, MD: US Department of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research; 2005. Available at http://www.fda.gov/cber/products/adacel.htm.
5. Food and Drug Administration. Product approval information-licensing action, package insert: BOOSTRIX. Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed BOOSTRIX. GlaxoSmithKline. Rockville, MD: US Department of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research; 2005. Available at http://www.fda.gov/cber/products/boostrix.htm.
6. Pichichero M.E., and Casey J.R. Acellular pertussis vaccines for adolescents. Pediatr Infect Dis J 24 6 Suppl (2005) S117-S126
7. Pichichero M.E., Rennels M.B., Edward K.M., et al. Combined tetanus, diphtheria, and 5-component pertussis vaccine for use in adolescents and adults. JAMA 293 (2005) 3003-3011
8. Ward J.I., Cherry J.D., Chang S.J., et al. Efficacy of an acellular pertussis vaccine among adolescents and adults. N Engl J Med 353 (2005) 1555-1563
9. Lee G.M., Lebaron C., Murphy T.V., et al. Pertussis in adolescents and adults: Should we vaccinate?. Pediatrics 115 (2005) 1675-1684
10. Purdy K.W., Hay J.W., Botteman M.F., and Ward J.I. Evaluation of strategies for use of acellular pertussis vaccine in adolescents and adults: A cost-benefit analysis. Clin Infect Dis 39 (2004) 20-28
11. Davis M.M., Broder K.R., Cowan A.E., et al. Physician attitudes and preferences about combined Tdap vaccines for adolescents. Am J Prev Med 31 (2006) 176-180
12. Freed G.L., Nahra T.A., and Wheeler J.R. Which physicians are providing health care to America's children? Trends and changes during the past 20 years. Arch Pediatr Adolesc Med 158 (2004) 22-26
13. Szilagyi P.G., Rand C.M., McLaurin J., et al. Delivering adolescent vaccinations in the medical home: A new era?. Pediatrics 121 Suppl 1 (2008) S15-S24
14. Klein J.D., McNulty M., and Flatau C.N. Adolescents' access to care: Teenagers' self-reported use of services and perceived access to confidential care. Arch Pediatr Adolesc Med 152 (1998) 676-682
15. Broder K.R., Cohn A.C., Schwartz B., et al. Adolescent immunizations and other clinical preventive services: A needle and a hook?. Pediatrics 121 Suppl 1 (2008) S25-S34
16. National vaccination coverage among adolescents aged 13-17 years-United States. Morbid Mortal Wkly Rep 2007 56 (2006) 885-888
17. Department of Health and Human Services. Healthy People 2010, Volume I, Chapter 14: Vaccination Coverage and Strategies. Available at http://www.healthypeople.gov/Document/HTML/Volume1/14Immunization.htm.
18. Davis M.M., Marin M., Cowan A.E., et al. Physician attitudes regarding breakthrough varicella disease and a potential second dose of varicella vaccine. Pediatrics 119 (2007) 258-264
19. Asch D.A., Jedrziewski M.K., and Christakis N.A. Response rates to mail surveys published in medical journals. J Clin Epidemiol 50 (1997) 1129-1136
20. Cummings S.M., Savitz L.A., and Konrad T.R. Reported response rates to mailed physician questionnaires. Health Serv Res 35 (2001) 1347-1355
21. Cull W.L., O'Connor K.G., Sharp S., and Tang S.F. Response rates and response bias for 50 surveys of pediatricians. Health Serv Res 40 (2005) 213-226
22. Crane L.A., Daley M.F., Barrow J., et al. Sentinel physician networks as a technique for rapid immunization policy surveys. Eval Health Prof 31 (2008) 43-64